Koen Raemdonck is an Assistant Professor at the Ghent Research Group on Nanomedicines (Department of Pharmaceutics, Ghent University, Belgium) and group leader within the Cancer Research Institute Ghent (CRIG). His work is mainly focused on exploring novel bio-inspired approaches for delivery of macromolecular therapeutics across intra-and extracellular biological barriers. He (co-)authored 50 peer-reviewed publications. For his research, he received several awards including the biennial National Prize of the Belgian Society of Pharmaceutical Sciences in 2011, the prize of the Royal Academy of Medicine in Belgium for scientific research in Pharmacy 2014 and the T. Nagai Postdoctoral Research Achievement award of the Controlled Release Society in 2016. Koen Raemdonck is an active member of various academic societies, including the Controlled Release Society (CRS).